Entera Bio (ENTX) Exchange Rate Effect (2025 - 2026)

Entera Bio (ENTX) posted quarterly Exchange Rate Effect of $4000.0 for Q1 2026, up 106.15% on a QoQ basis from -$65000.0 in Q4 2025.

Entera Bio (ENTX) Exchange Rate Effect (2025 - 2026) Analysis & Trends

Entera Bio (ENTX) has reported Exchange Rate Effect for 2 consecutive years, with $4000.0 the latest figure, recorded in Q1 2026.

Quarterly Exchange Rate Effect changed N/A year-over-year to $4000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$61000.0 (changed N/A YoY) and the FY2025 annual result came in at -$36000.0, changed N/A from the prior year.
Exchange Rate Effect grew to $4000.0 in Q1 2026 per ENTX's latest filing, from -$65000.0 in the prior quarter.
Over the last five years, Exchange Rate Effect for ENTX reached as high as $4000.0 in Q1 2026 and fell as low as -$65000.0 in Q4 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Exchange Rate Effect (Qtr)
1	Oculis Holding AG	66,621.14 Bn	66,620.85 Bn	-	619,347.27
2	Nanobiotix	1,915.18 Bn	1,915.11 Bn	-	-
3	Akari Therapeutics	1,014.18 Bn	1,014.18 Bn	-	-
4	BeOne Medicines	471.27 Bn	466.48 Bn	1.35 Bn	19.32 Mn
5	Vertex Pharmaceuticals	121.81 Bn	114.57 Bn	2.59 Bn	-40.30 Mn
6	Regeneron Pharmaceuticals	69.58 Bn	60.82 Bn	3.31 Bn	-900,000.00
7	Belite Bio	62.72 Bn	62.72 Bn	-	-
8	Argenx Se	55.51 Bn	50.33 Bn	1.41 Bn	-
9	Revolution Medicines	37.35 Bn	37.35 Bn	-	-
10	Entera Bio	186.78 Mn	182.64 Mn	-	4,000.00

Download Data